Dr. Priya Jayachandran
Claim this profileLos Angeles General Medical Center
Studies Breast Cancer
Studies Pancreatic Cancer
5 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage IV
PR negative
2Pancreatic Cancer
Stage IV
HER2 negative
PR negative
Affiliated Hospitals
Clinical Trials Priya Jayachandran is currently running
Sarilumab + Capecitabine
for Breast Cancer
This study looks to advance a novel and potent strategy to eliminate minimal residual disease (MRD) in triple negative breast cancer (TNBC) present even after multimodal treatment, thereby improving survival and increasing cure rate in this aggressive cancer. Patients with locally advanced TNBC are at high risk of developing lethal metastatic disease within 2 years of diagnosis, especially for those without a pathologic complete response (pCR) after neoadjuvant chemotherapy. The high risk occurs despite surgical excision of the primary tumor and axillary lymph nodes to eliminate residual disease.
Recruiting1 award Phase 1 & 212 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
More about Priya Jayachandran
Clinical Trial Related12 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Priya Jayachandran has experience with
- ARX788
- Controlled Low Calorie Diet
- Capecitabine
- Sarilumab
- Carvedilol
- Trastuzumab Emtansine
Breakdown of trials Priya Jayachandran has run
Breast Cancer
Breast cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Priya Jayachandran specialize in?
Priya Jayachandran focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Priya Jayachandran currently recruiting for clinical trials?
Yes, Priya Jayachandran is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Priya Jayachandran has studied deeply?
Yes, Priya Jayachandran has studied treatments such as ARX788, Controlled Low Calorie Diet, Capecitabine.
What is the best way to schedule an appointment with Priya Jayachandran?
Apply for one of the trials that Priya Jayachandran is conducting.
What is the office address of Priya Jayachandran?
The office of Priya Jayachandran is located at: Los Angeles General Medical Center, Los Angeles, California 90033 United States. This is the address for their practice at the Los Angeles General Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.